Biohope Signs Commercial Agreement with TEMA Ricerca for the Italian Market.

Published On: February 19th, 2020

Biohope, a Spanish biotechnological company that investigates, develops and commercializes unique IVD solutions in the field of chronic inflammation, signed with TEMA Ricerca SRL an agreement to commercialize the Immunobiogram© for Renal Transplant  in Italy.

The diagnostic unit of TEMA RICERCA operates in the market of certified public and private lab analysis, to provide solutions in the clinical monitoring of molecules.

The agreement includes two phases: initially, the Immunobiogram© will be used in a research study with some leading Italian centers in renal transplant, and later on the Immunobiogram© will be commercially available for the whole Italian market.